Accueil
»
Bourse
»
Actions Paris
»

Consensus des Analystes Sanofi

Cotation du 03/06/2020 à 17h19 Sanofi +0,03% 88,850€
  • SAN - FR0000120578
  • SRD
  • PEA
  •   PEA-PME
  • Consensus Renforcer
  • + Ajouter à : Mes portefeuilles | Mes Listes

Objectif de cours au 03/06/2020

104,079 €
Potentiel de +17%
cours actuel 88,850€

Note médiane des 25 analystes

1,8
5 Vendre 4 Alléger 3 Conserver 2 Renforcer 1 Acheter

Evolution des recommandations

Recommandations 03/06/2019 03/09/2019 03/12/2019 03/03/2020 03/06/2020
Acheter 9 11 13 12 12
Renforcer 5 5 4 6 7
Conserver 9 8 6 6 6
Alléger - - 1 1 -
Vendre - - - - -
Nb d'analystes 23 24 24 25 25
Note Médiane 2,00 1,88 1,79 1,84 1,76
Historique des objectifs 86,219€ 87,657€ 91,591€ 102,216€ 104,079€

Prévisions

2019 2020 2021
Chiffre d'affaires 36 126,00 37 355,40 39 028,01
EBITDA 11 904,00 11 463,14 12 464,21
EBIT 9 758,00 10 023,82 10 879,75
Résultat Net 2 806,00 5 716,62 6 079,87
Flux de trésorerie disponible 5 928,00 5 857,74 7 585,65
Dette nette 16 506,00 15 526,24 12 293,47
PER 6,00 6,19 6,74
Copyright ©2020, S&P Global Market Intelligence. Reproduction of CIQ Estimates in any form is prohibited except with the prior written permission of S&P Global Market Intelligence. CIQ Estimates are not investment advice and a reference to a particular investment or security, a credit rating or any observation concerning a security or investment provided in CIQ Estimates is not a recommendation to buy, sell or hold such investment or security or make any other investment decisions. S&P Global Market Intelligence, its affiliates and their third-party providers (together, “S&P Global”) do not guarantee the accuracy, adequacy, completeness or availability of any information and are not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P GLOBAL DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P Global be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of CIQ Estimates.

Actualités Sanofi

Plus d'actualités